Formulation: Advances in formulation development & manufacture for solid dosage, injectables, liquids & specialty dosage forms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Formulation
Oral tablets & capsules. Solutions, suspensions, injectables, as well as topical ointments, gels & solutions. Lyophilization (freeze drying), spray drying, hot-melt extrusion & nanocrystal technology.

Tackling challenges in the development of fixed-dose combinations

April 2, 2014

Pharmaceutical Technology

Anil Kane from Patheon spoke to Pharmaceutical Technology about the challenges in the development of FDCs and discussed how to integrate quality-by-design (QbD) in the manufacturing process of FDCs.

Drug Encapsulation for Patient-Centric Dosing

April 2, 2014

Pharmaceutical Technology

Encapsulation technologies for solubility/bioavailability enhancement, controlled release, and formulation of drug combinations and patient-friendly dosage forms.

Navigating the Regulatory Landscape of Combination Products

April 2, 2014

Pharmaceutical Technology

Mark D. Kramer talks about combination products from a regulatory perspective and explains the implications of FDA's final rule on current GMP requirements for combination products.

A Survey of Postapproval CMC Changes to Generic Drugs

March 2, 2014

Pharmaceutical Technology

A survey on postapproval CMC changes was conducted to better understand reporting categories, nature and risks, and review outcomes.

Manufacturers Struggle with Breakthrough Drug Development

March 2, 2014

Pharmaceutical Technology

Accelerated testing and production create challenges in documenting product quality.

Pulmonary Drug Delivery—Particle Engineering for Inhaled Therapeutics

February 2, 2014

Pharmaceutical Technology

Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.

FDA Focuses on Drug Appearance and Attributes

February 2, 2014

Pharmaceutical Technology

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.

National Cancer Institute Announces Genetic Sequencing Trial

January 30, 2014

NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes.

The Role of NMR and Mass Spectroscopy in Glycan Analysis

January 2, 2014

Pharmaceutical Technology

NMR analysis provides crucial structural information of synthesized glycans while LC-MS/MS is ideal for quantitation of free sugars in biological matrices.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here